Perfil sintomático e socioeconômico de adultos um ano após COVID-19

Autores

DOI:

10.24281/rremecs2024.9.15.226239

Palavras-chave:

COVID-19, COVID Longa, Sintomas, Aspectos Socioeconômicos

Resumo

Identificar a prevalência de sintomas persistentes da COVID-19, suas características e correlações com fatores socioeconômicos. Buscou-se compreender como esses fatores podem estar relacionados com a especificidade dos sintomas um ano ou mais após a infecção pelo vírus. Realizou-se um estudo transversal com 381 pacientes. Para a coleta, um questionário online desenvolvido na plataforma Microsoft Forms abrangeu seis grupos de questões. Os pacientes foram divididos em dois grupos, sendo eles: recuperados e sintomáticos. Fadiga, déficit de memória, dor de cabeça, perda de cabelo e tosse emergem como principais sintomas relatados em uma população que continua a sofrer com sintomas persistentes. É observado que o sexo feminino, os não vacinados, a faixa etária de 30 a 39 anos, os que alegaram receber uma renda mensal de até um salário mínimo, aqueles que utilizam o SUS e aqueles que tiveram 3 ou mais infecções são os mais acometidas pela patologia.
Descritores: COVID-19, COVID Longa, Sintomas, Aspectos Socioeconômicos.

 

Symptomatic and socioeconomic profile of adults one year after COVID-19

Abstract: To identify the prevalence of persistent COVID-19 symptoms, their characteristics, and correlations with socioeconomic factors. The aim was to understand how these factors may be related to the specificity of symptoms one year or more after infection with the virus. A cross-sectional study was conducted with 381 patients. Data collection was performed using an online questionnaire developed on the Microsoft Forms platform, covering six groups of questions. The patients were divided into two groups: recovered and symptomatic. Fatigue, memory deficit, headache, hair loss, and cough emerged as the main symptoms reported in a population that continues to suffer from persistent symptoms. It was observed that females, the unvaccinated, those aged 30 to 39, those who reported receiving a monthly income of up to one minimum wage, those who use the public health system (SUS), and those who had three or more infections are the most affected by the condition.
Descriptors: COVID-19, Long COVID, Symptoms, Socioeconomic Aspects.

 

Perfil sintomático y socioeconómico de los adultos a un año de la COVID-19

Resumen: Identificar la prevalencia de los síntomas persistentes de COVID-19, sus características y correlaciones con factores socioeconómicos. El objetivo era comprender cómo estos factores pueden estar relacionados con la especificidad de los síntomas un año o más después de la infección por el virus. Se realizó un estudio transversal con 381 pacientes. La recolección de datos se llevó a cabo mediante un cuestionario en línea desarrollado en la plataforma Microsoft Forms, que abarcó seis grupos de preguntas. Los pacientes se dividieron en dos grupos: recuperados y sintomáticos. La fatiga, el déficit de memoria, el dolor de cabeza, la pérdida de cabello y la tos surgieron como los principales síntomas reportados en una población que sigue sufriendo síntomas persistentes. Se observó que las mujeres, los no vacunados, las personas de 30 a 39 años, los que informaron recibir un ingreso mensual de hasta un salario mínimo, los que utilizan el sistema de salud pública (SUS) y aquellos que tuvieron tres o más infecciones son los más afectados por la condición.
Descriptores: COVID-19, COVID Prolongado, Síntomas, Aspectos Socioeconómicos.

Referências

Groff D, et al. Short-term and long-term rates of postacute sequelae of sars-cov-2 infection: a systematic review. JAMA Network Open. 2021; 4(10):e2128568.

Crook H, et al. Long covid-mechanisms, risk factors, and management. BMJ. 2021; 374(1648).

National institute for health and care excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: NICE. 2021.

World health organization (WHO). A clinical case definition of post COVID-19 condition. Delphi Consensus. 2021; 22(4):e102-e107.

Lopez-leon S, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Scientific Reports. 2021; 11(1).

Yoo SM, et al. Factors associated with post-acute sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse Cohort. Journal of General Internal Medicine. 2022; 37:1988-1995.

Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021; 15(3):869-875.

Sungnak W, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nature Medicine. 2020; 26(5):681-687.

Wu Z, Mcgoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 23(13).

Gemelli A. COVID-19 Post-Acute Care Study Group. Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res. 2020; 32(8):1613-1620.

Laviolette L, Laveneziana P. Dyspnoea: a multidimensional and multidisciplinary approach. European Respiratory Journal, European Respiratory Society. 2014; 43(6).

Morland K, et al. Neighborhood characteristics associated with the location of food stores and food service places. Am J Prev Med. 2002; 22(1):23-9.

Townsend L, et al. Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Annals of the American Thoracic Society. 2021; 18(6):997-1003.

Tansey CM, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. JAMA. 2007; 167(12):1312-1320.

Douaud G, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022; 604:697-707.

Fernández-castañeda A, et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022; 185(14):2452-2468.

Premraj L, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022; 434:120162.

Taquet M, et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry. 2021; 8(5):416-427.

Taquet M, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. The Lancet Psychiatry. 2022; 9(10):815-827.

Landi F, et al. Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clinical and Experimental Research. 2020; 32(8):1613-1620.

Poyraz BC, et al. Psychiatric morbidity and protracted symptoms after COVID-19. Psychiatry Research. 2021; 295.

Frontera JÁ, et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. Journal of the Neurological Sciences. 2021; 426.

Peghin M, et al. Post-COVID-19 syndrome 2 years after the first wave: the role of humoral response, vaccination and reinfection. Open Forum Infectious Diseases. 2023; 10(7).

National institute for health and care excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: NICE. 2024.

Jylhä M. What is self-rated health and why does it predict mortality?: towards a unified conceptual model. Soc Sci Med. 2009; 69:307-316.

Aiyegbusi O, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021; 114(9):428-442.

Malik P, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL): a systematic review and meta-analysis. J Med Virol. 94(1):253-262.

Usher K, Bhullar N, Jackson D. Life in the pandemic: social isolation and mental health. J Clin Nurs. 2020; 29:2756-2757.

Zhang Y, et al. The COVID-19 pandemic on mental health and quality of life among local residents in Liaoning Province, China: a cross-sectional study. Int J Environ Res Public Health. 2020; 17(7):2381.

Perlis RH, et al. Prevalence and correlates of long COVID symptoms among US adults. JAMA Network Open. 2022; 5(10):e2238804.

Talhari C, et al. Prevalence of and risk factors for post-COVID: results from a survey of 6,958 patients from Brazil. An Acad Bras Ciênc. 2023; 95(1):e20220143.

Al-Aly Z, BOWE B, XIE Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022; 28(7):1461-1467.

Ayoubkhani D, et al. Risk of long COVID in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study. Open Forum Infect Dis. 2022; 9(9).

Publicado

01-12-2024
Métricas
  • Visualizações 0
  • pdf downloads: 0

Como Citar

PATARA, D. P. de B. .; FONTANA, C. E. . Perfil sintomático e socioeconômico de adultos um ano após COVID-19. Revista Remecs - Revista Multidisciplinar de Estudos Cientí­ficos em Saúde, [S. l.], v. 9, n. 15, p. 226–239, 2024. DOI: 10.24281/rremecs2024.9.15.226239. Disponível em: https://revistaremecs.com.br/index.php/remecs/article/view/1715. Acesso em: 19 jan. 2025.

Edição

Seção

Artigos